EUVIMEDEUVIMED entdecken
LeserbriefRandomisierte kontrollierte Studie

Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial

Baltazar Sanabria, Marcelo Zanolli Medeiros, Hélio Amante Miot iD, Paulo Müller Ramos iD

Journal of the European Academy of Dermatology and Venereology · 2026-07 · 40 (7)

DOI: 10.1111/jdv.70237 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 02.12.2025. Verfasst von Baltazar Sanabria und 3 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

5‐alpha reductase inhibitors, alopeciaandrogenetic alopeciaclinical trialdutasteridehair loss, scalp injectionsmanmesotherapyrandomized clinical trialtreatment, injections

Autor:innen und Institutionen

  • Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil.
  • Department of Dermatology, FMB-UNESP, Botucatu, SP, Brazil.

ORCID-Profile: Hélio Amante Miot, Paulo Müller Ramos

Zitieren

APA

Sanabria, B., Medeiros, M. Z., Miot, H. A., & Müller Ramos, P. (2026). Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial. Journal of the European Academy of Dermatology and Venereology, 40(7). https://doi.org/10.1111/jdv.70237

Vancouver

Sanabria B, Medeiros MZ, Miot HA, Müller Ramos P. Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial. Journal of the European Academy of Dermatology and Venereology. 2026;40(7). doi:10.1111/jdv.70237

BibTeX
@article{Sanabria2026,
  author = {Sanabria, Baltazar and Medeiros, Marcelo Zanolli and Miot, Hélio Amante and Müller Ramos, Paulo},
  title = {Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  volume = {40},
  number = {7},
  doi = {10.1111/jdv.70237}
}
Kostenlos starten →